FDA, rna and Flu Shot
Digest more
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots
Moderna advances messenger RNA platform technologies Therapeutics pipeline spans vaccines and disease targets nasdaq index inclusion reflects biotech scale Moderna, Inc. (NASDAQ:MRNA) operates within the biotechnology sector and remains a recognized component of the broader nasdaq index,
The American pharmaceutical company Moderna announced that the United States Food and Drug Administration (FDA) has refused to review the application for authorization for its flu vaccine based on mes
Jan 6 (Reuters) - Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology in manufacturing their vaccines, a Bayer spokesperson confirmed.
DURING THE covid-19 pandemic new vaccines were rolled out with unprecedented speed. The fastest to arrive were jabs built from molecules of messenger RNA (mRNA) designed to teach the body how to fight off the disease-causing virus. By late 2021, mRNA ...